Regenxbio
RGNX
RGNX
85 hedge funds and large institutions have $401M invested in Regenxbio in 2017 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 33 increasing their positions, 21 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.5% less ownership
Funds ownership: 69.11% → 68.61% (-0.5%)
Holders
85
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$45.8M | |
| 2 | +$24.5M | |
| 3 | +$18.9M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$9.32M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$5.78M |
Top Sellers
| 1 | -$11.6M | |
| 2 | -$6.58M | |
| 3 | -$6.53M | |
| 4 |
Jennison Associates
New York
|
-$5.42M |
| 5 |
NCM
Numina Capital Management
New York
|
-$3.44M |